VERTEX PHARMACEUTICALS INC / MA (VRTX) /
The profitability of VERTEX PHARMACEUTICALS INC / MA over the past 10 years
Chart VERTEX PHARMACEUTICALS INC / MA: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →VERTEX PHARMACEUTICALS INC / MA reported net income of $3.95B in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $10.35B and operating income of $4.17B. It reported a profit in 8 of the 10 years shown, and a loss in fiscal 2016 and 2024.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $10.35B* | $4.17B | $3.95B |
| 2024ended Dec 31, 2024 | $9.49B* | -$232.9M | -$535.6M |
| 2023ended Dec 31, 2023 | $8.61B* | $3.83B | $3.62B |
| 2022ended Dec 31, 2022 | $7.85B* | $4.31B | $3.32B |
| 2021ended Dec 31, 2021 | $6.67B* | $2.78B | $2.34B |
| 2020ended Dec 31, 2020 | $5.47B* | $2.86B | $2.71B |
| 2019ended Dec 31, 2019 | $3.62B* | $1.2B | $1.18B |
| 2018ended Dec 31, 2018 | $2.64B* | $635.15M | $2.1B |
| 2017ended Dec 31, 2017 | $2.21B* | $123.24M | $263.48M |
| 2016ended Dec 31, 2016 | $1.49B* | $9.94M | -$112.05M |
Fiscal years as VERTEX PHARMACEUTICALS INC / MA reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on VERTEX PHARMACEUTICALS INC / MA
- The revenue of VERTEX PHARMACEUTICALS INC / MA
- The cash flow of VERTEX PHARMACEUTICALS INC / MA
- The debt of VERTEX PHARMACEUTICALS INC / MA
- All of VERTEX PHARMACEUTICALS INC / MA's financials, charted
Companies of a similar size
- SPGIS&P Global Inc.
- PGRPROGRESSIVE CORP/OH/
- UBERUber Technologies, Inc
- FTNTFORTINET, INC.
- LMTLOCKHEED MARTIN CORPORATION
Not investment advice. This page shows what VERTEX PHARMACEUTICALS INC / MA filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.